Bioreactors Market Will Reach USD 2154.4 Million By 2028 With A CAGR of 6.0% - Valuates Reports
BANGALORE, India, May 5, 2022 /PRNewswire/ -- Bioreactors market is Segmented by Type - Disposable, Reusable, by Application - Research and Development, Biopharmaceutical, Others. Global Opportunity Analysis and Industry Forecast 2022 - 2028. It is published in Valuates Reports under the Medical Devices & Equipment Category.
Bioreactors market size is estimated to be worth USD 1523.1 million in 2022 and is forecast to be a readjusted size of USD 2154.4 million by 2028 with a CAGR of 6.0% during the review period.
Major factors driving the growth of the bioreactors market are
The bioreactors market is growing due to increased funding from private and government organizations for vaccine research and development, as well as increased demand from the biopharmaceutical industry and monoclonal antibiotics.
Furthermore, the number of clinical and pre-clinical trial studies is increasing, which is driving the bioreactors market forward.
Browse The Table of Contents And List of Figures At https://reports.valuates.com/reports/QYRE-Auto-16C2870/covid-19-impact-on-global-bioreactors
TRENDS INFLUENCING THE GROWTH OF BIOREACTORS MARKET
The bioreactors market is expected to grow due to the increasing use of bioreactors in various R&D projects. In the development and production of engineered biological products, bioreactors are essential. They mimic the in vivo microenvironment of tissue growth while also providing various mechanical and biochemical signals to stem cells in order to successfully generate transplantable organs or tissues.
Biopharmaceutical manufacturing, which includes enzymes, vaccines, antibodies, growth factors, and hormones, is a difficult task in which small differences in manufacturing conditions can have a significant impact on product quality, efficacy, safety, and yield. Because the majority of commercial biopharmaceutical proteins are complex glycoproteins, they must be manufactured under strict conditions. Bioreactors aid in the production of biopharmaceuticals under controlled and repeatable conditions, all while adhering to GMP guidelines. This factor is expected to further drive the growth of the bioreactors market.
The market value will be boosted by rising bioreactor demand for clinical studies and biopharma manufacturers' focus on innovation. The demand for small-scale bioreactors has grown as the number of pre-clinical and clinical-stage studies in the development of various therapeutic drugs for rare and chronic diseases has increased. The bioreactors market revenue is also boosted by pharmaceutical manufacturers' continued focus on product innovation and increased R&D expenditure.
COVID-19 has sparked a significant increase in demand for preventive vaccines and effective treatment therapeutics. Several pharmaceutical companies have increased their production capacities in order to meet rising drug demand, boosting bioreactor sales during the pandemic. Additionally, increased vaccine development R&D activities around the world have created the potential for clinical-stage bioreactors. This in turn is expected to drive the growth of the bioreactors market.
Get Your Sample Today: https://reports.valuates.com/request/sample/QYRE-Auto-16C2870/Global_Bioreactors_Market
BIOREACTORS MARKET SHARE ANALYSIS
Based on type, The single-use bioreactor is expected to be the most lucrative segment. Single-use bioreactor systems have become widely accepted in today's biopharmaceutical manufacturing methods that prioritize high product yield. Single-use bioreactors' flexibility, cost-effectiveness, and high mass production will increase demand, thereby affecting growth.
Based on application, Research and development are expected to be the most lucrative segment.
Based on region, Asia-Pacific is expected to be the most lucrative region. Asian companies, including domestic players and international giants, are estimated to be building about half of all new bioprocessing facilities around the world. In the near future, this is expected to be a major driving force in the Asia Pacific market. Because of its high adoption of single-use technology, China is expected to be at the forefront.
Inquire For Customization: https://reports.valuates.com/request/customisation/QYRE-Auto-16C2870/Global_Bioreactors_Market
Market By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Inquire For Regional Report: https://reports.valuates.com/request/regional/QYRE-Auto-16C2870/Global_Bioreactors_Market
Key players
- PBS Biotech
- Eppendorf
- Kühner
- TAP Biosystems
- Sartorius
- Celltainer
- Pall(Danaher)
- Merck Millipore
- Eppendorf
- 2mag AG
- Finesse
- Sartorius
- Thermo Fisher
- Amprotein
- Applikon
- GE Healthcare
- SYNTHECON
- Solaris
Inquire For Chapter Cost: https://reports.valuates.com/request/chaptercost/QYRE-Auto-16C2870/Global_Bioreactors_Market
Buy Now for Single User + Covid-19 Impact: https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-16C2870&lic=single-userv
SUBSCRIPTION
We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.
SIMILAR REPORTS
- The global Parallel Bioreactors market was valued at USD 283.6 million in 2020 and it is expected to reach USD 574 million by the end of 2027, growing at a CAGR of 10.6% during 2021-2027.
- Micro Bioreactors market size is estimated to be worth USD 147 million in 2022 and is forecast to a readjusted size of USD 246.5 million by 2028 with a CAGR of 9.0% during the review period.
- Perfusion Bioreactors market size is estimated to be worth USD 745.3 million in 2022 and is forecast to a readjusted size of USD 1257.5 million by 2028 with a CAGR of 9.1% during the review period.
- The global Single-use Bioprocessing market size is projected to reach USD 6956.3 million by 2027, from USD 3905.3 million in 2020, at a CAGR of 10.1% during 2021-2027.
- The global cell culture market accounted for USD 16,107.7 million in 2019 and is expected to reach USD 36,926.8 million by 2027, registering a CAGR of 10.9% from 2020 to 2027.
- The Global Bioinformatics Market Size is USD 8,614.29 Million in 2019, and is projected to reach USD 24,731.61 Million by 2027, growing at a CAGR of 13.4% from 2020 to 2027.
- Global Bioreactors and Fermenters Market Insights and Forecast to 2028
- Global Packed Bed Bioreactors Market Research Report 2022
- Global Cell Culture Bioreactors Market Insights, Forecast to 2028
- Global Portable Bioprocessing Bioreactors Market Insights and Forecast to 2028
- Global and United States Industrial Bioreactors Market Insights, Forecast to 2027
- Global Hollow Fiber Bioreactors Market Insights and Forecast to 2028
- Global Disposable Bioreactors Market Insights and Forecast to 2028
Click Here To See Related Reports on Bioreactors Market
About Us:
Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.
Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.
To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains a detailed research methodology employed to generate the report. Please also reach our sales team to get the complete list of our data sources.
Contact Us:
Valuates Reports
[email protected]
For U.S. Toll-Free Call 1-(315)-215-3225
For IST Call +91-8040957137
WhatsApp: +91-9945648335
Website: https://reports.valuates.com
Twitter - https://twitter.com/valuatesreports
Logo: https://mma.prnewswire.com/media/1082232/Valuates_Reports_Logo.jpg
Share this article